# Alyglo

NDC: 61476-104
Generic name: Human immunoglobulin G
Labeler / Manufacturer: GC Biopharma Corp.
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: LIQUID
Routes: INTRAVENOUS
Marketing started: 20231215

FDA application: BLA125743

## Active ingredients

- HUMAN IMMUNOGLOBULIN G: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61476-104"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61476-104